UUKPXXBDUCDZDA-KAFVXXCXSA-N
|
|
|
- CAS号:
- 740790-94-7
- 英文名:
- UUKPXXBDUCDZDA-KAFVXXCXSA-N
- 英文别名:
- T705RTP,T 705RTP;UUKPXXBDUCDZDA-KAFVXXCXSA-N;(Favipiravir Metabolite RTP)
- 中文名:
- UUKPXXBDUCDZDA-KAFVXXCXSA-N
- 中文别名:
- 法匹拉韦杂质29;化合物 T13075
- CBNumber:
- CB93401218
- 分子式:
- C10H15FN3O15P3
- 分子量:
- 529.1568862
- MOL File:
- 740790-94-7.mol
|
|
|
UUKPXXBDUCDZDA-KAFVXXCXSA-N化学性质
-
熔点:
-
>123°C (dec.)
-
|
-
储存条件:
-
Hygroscopic, -86°C Freezer, Under inert atmosphere
-
|
-
溶解度:
-
Water (Slightly)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Light Yellow to Light Green
-
|
UUKPXXBDUCDZDA-KAFVXXCXSA-N性质、用途与生产工艺
T-705RTP 是一种具有具有选择性和 GTP 竞争性的流感病毒 RNA 聚合酶 (RNA polymerase) 抑制剂，IC50 为 0.14 μM，Ki 为 1.52 μM。T-705RTP 是 T-705 的活性三磷酸盐代谢产物，具有有效的抗流感病毒活性。
IC50: 0.14 μM (Influenza virus RNA polymerase)
Ki: 1.52 μM (Influenza virus RNA polymerase)
T-705RTP and T-705RMP are detected in MDCK cells treated with T-705. T-705RTP inhibits influenza virus RNA polymerase activity in a dose-dependent and a GTP-competitive manner.
T-705RTP inhibits the incorporation of ATP and GTP in a competitive manner with K
i
values of 7.72 and 1.56 μM, respectively. T-705RTP inhibits the incorporation of CTP in a mixed-type manner with a K
i
value of 11.3 μM, and also inhibits the incorporation of UTP in a noncompetitive manner.
The incorporation of a single molecule of T-705RTP (10-1000 μM) inhibits influenza virus RNA strand extension.
UUKPXXBDUCDZDA-KAFVXXCXSA-N
上下游产品信息
上游原料
下游产品
UUKPXXBDUCDZDA-KAFVXXCXSA-N
生产厂家
740790-94-7, UUKPXXBDUCDZDA-KAFVXXCXSA-N 相关搜索:
- 化合物 T13075
- 法匹拉韦杂质29
- 740790-94-7
- (Favipiravir Metabolite RTP)
- T705RTP,T 705RTP
- UUKPXXBDUCDZDA-KAFVXXCXSA-N